Related Experiment Video
Updated: Aug 9, 2026
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines
Marion M Schuierer1, Elisabeth Graf, Ken-Ichi Takemaru
1University of Regensburg, Institute of Pathology, Franz-Josef-Straus-Allee 11, 93053 Regensburg, Germany.
Aim:
To analyse the Chibby expression and its function in colon carcinoma cell lines and colorectal carcinoma (CRC).
Methods:
Chibby expression levels were investigated by quantitative RT-PCR in a panel of seven different colon carcinoma cell lines. By sequencing, we analysed mutational status of Chibby. To test whether Chibby exhibited effects on beta-catenin signalling in colon carcinoma cells, we transfected SW480 cells with Chibby expression plasmid and, subsequently, analysed activity of beta-catenin and tested for alterations in cellular phenotype. In addition, we examined Chibby mRNA levels in samples of colorectal carcinomas and adjacent normal tissues by using quantitative RT-PCR and hybridised gene chips with samples from CRC and normal tissues.
Results:
Chibby mRNA expression was strongly down-regulated in colon carcinoma cell lines in comparison to normal colon epithelial cells and no mutation in any of the examined colon carcinoma cell lines was found. Further, we could show that Chibby inhibited beta-catenin activity in TOPflash assays when over-expressed in SW480 cells. Proliferation and invasion assays with Chibby transfected SW480 cells did not reveal profound differences compared to control cells. In contrast to these in vitro data, quantitative RT-PCR analyses of Chibby mRNA levels in CRC tumor samples did not show significant differences to specimens in adjacent non-cancerous tissue. Consistent with these findings, gene chips analysing tissue samples of tumors and corresponding normal tissue did not show altered Chibby expression.
Conclusion:
Altered Chibby expression might be observed in vitro in different colon carcinoma cell lines. However, this finding could not be confirmed in vitro in CRC tumors, indicating that Chibby is not likely to promote CRC tumor development or progression. As Chibby is an important inhibitor of beta-catenin signalling, our data implicate that the usability of colon carcinoma cell lines for in vitro studies analysing the Wnt/beta-catenin pathway in colorectal carcinoma needs extensive verification.
Insights
Chibby expression was down-regulated in colon cancer cell lines but not in colorectal tumors. This suggests Chibby does not drive colorectal cancer (CRC) progression, questioning the use of cell lines for Wnt/beta-catenin pathway studies.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- Chibby is a protein involved in regulating cellular pathways.
- The Wnt/beta-catenin signaling pathway plays a crucial role in colorectal cancer (CRC) development.
- Understanding Chibby's role in CRC is important for therapeutic strategies.
Purpose of the Study:
- To investigate Chibby expression and its functional role in colon carcinoma cell lines and human colorectal carcinoma (CRC) tissues.
- To determine if Chibby influences beta-catenin signaling in colon cancer cells.
- To assess the relevance of in vitro findings to in vivo CRC progression.
Main Methods:
- Quantitative RT-PCR was used to measure Chibby mRNA levels in colon cancer cell lines and CRC tissues.
- Chibby's mutational status was analyzed by sequencing.
- Functional assays involved transfecting SW480 cells to assess beta-catenin activity and cellular phenotype.
- Gene chip hybridization was performed on CRC and normal tissue samples.
Main Results:
- Chibby mRNA was significantly down-regulated in colon carcinoma cell lines compared to normal cells; no mutations were found.
- Overexpression of Chibby inhibited beta-catenin activity in SW480 cells, but did not significantly alter proliferation or invasion.
- Chibby mRNA levels in CRC tumors were not significantly different from adjacent normal tissues, and gene chip data confirmed no altered expression in tumors.
- In vitro findings of altered Chibby expression in cell lines were not replicated in CRC tumor samples.
Conclusions:
- While Chibby expression is altered in colon carcinoma cell lines in vitro, this is not observed in colorectal carcinoma tumors.
- Chibby is unlikely to promote colorectal cancer development or progression.
- The study highlights the need for extensive verification of colon carcinoma cell line utility for in vitro Wnt/beta-catenin pathway research in CRC.
Related Concept Videos
02:34Inhibition of Cdk Activity
01:23Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...